Research Article
Clinicopathologic Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer
Table 5
Univariable and multivariable analyses of clinicopathologic factors associated with RFS.
| Characteristics | Univariable analysis | Multivariable analysis† | HR (95% CI) | value | HR (95% CI) | value |
| Age, yrs | 1.06 (1.02–1.11) | 0.010 | 1.06 (1.01–1.11) | 0.023 | Females | 2.10 (1.02–4.34) | 0.045 | | | Histology, different vs. same | 2.96 (1.39–6.33) | 0.005 | 2.59 (1.14–5.88) | 0.023 | Smoking history | 2.29 (1.14–4.63) | 0.020 | | | FEV1 | 1.00 (0.99–1.02) | 0.855 | | | DLCO | 1.01 (0.99–1.03) | 0.314 | | | dNLR | 1.59 (1.05–2.40) | 0.028 | | | Neutrophile granulocyte, 109 | 1.47 (1.14–1.89) | 0.003 | 1.30 (1.01–1.69) | 0.046 | Number of lesions, >2 vs. 2 | 1.69 (0.82–3.47) | 0.156 | | | Largest nodule size, >2 vs. <2 cm | 2.27 (1.09–4.72) | 0.028 | | | TNM stage, IB-IV vs. IA | 2.60 (1.19–5.68) | 0.016 | | | Pleural invasion | 2.81 (1.31–6.02) | 0.008 | 2.36 (1.07–5.18) | 0.032 |
|
|
BMI = body mass index; DLCO = diffusing capacity for carbon monoxide; dNLR = derive neutrophil-to-lymphocyte radio; FEV1 = forced expiratory volume in 1 second; LDH = lactate dehydrogenase; RFS = recurrence-free survival.
|